Alzamend Neuro Inc (ALZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
01-2021 | 10-2020 | 09-2020 | 07-2020 | 06-2020 | |
Operating Expenses | 1,116 | 1,298 | 1,009 | 1,318 | 0 |
Operating Income | -1,116 | -1,298 | -1,009 | -1,318 | N/A |
Interest Expense | 66 | 51 | 0 | 0 | 0 |
Other Income | 62 | -6 | 2 | 2 | 0 |
Pre-tax Income | -1,119 | -1,354 | -1,007 | -1,317 | 0 |
Net Income Continuous | -1,119 | -1,354 | -1,317 | -1,317 | N/A |
Net Income | $-1,119 | $-1,354 | $-1,317 | $-1,317 | $N/A |
EPS Basic Total Ops | -3.00 | -3.00 | N/A | -3.00 | N/A |
EPS Basic Continuous Ops | -2.32 | -2.81 | N/A | -2.73 | N/A |
EPS Diluted Total Ops | -3.00 | -3.00 | N/A | -3.00 | N/A |
EPS Diluted Continuous Ops | -2.32 | -2.81 | N/A | -2.73 | N/A |
EBITDA(a) | $-1,116 | $-1,298 | $-1,009 | $-1,318 | $N/A |